WA Centre for Health and Ageing,
Led by WACHA’s Professor Christopher Etherton-Beer, the OptiMed deprescribing study was a double-blind RCT in RACFs where two…
Led by WACHA’s Professor Christopher Etherton-Beer, the OptiMed deprescribing study was a double-blind RCT in RACFs where two…
The OptiMed deprescribing study was a double-blind RCT in RACFs where two pharmacists chose the medicines to target for…
AbstractBackground. potentially harmful polypharmacy is very common in older people living in aged care facilities. To date…
Available now! The most anticipated RCT in deprescribing - the double blind RCT known as the Opti-Med study is now in press.